NSC |
Compound |
Enrichment |
Correlation |
NSC 119915 |
3-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)propanoic acid |
0.0135588245836371 |
0.28103901 |
NSC 126228 |
Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) |
0.0135588245836371 |
0.26467482 |
NSC 173552 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.0135588245836371 |
0.40849807 |
NSC 300289 |
Pinafide |
0.0135588245836371 |
0.12344963 |
NSC 328477 |
3'-Chloro-3-nitro-o-salicylotoluidide |
0.0135588245836371 |
0.13309899 |
NSC 33570 |
Null |
0.0135588245836371 |
0.42913139 |
NSC 339579 |
7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate |
0.0135588245836371 |
0.37236493 |
NSC 351521 |
Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) |
0.0135588245836371 |
0.4119243 |
NSC 359239 |
Antibiotic X-14766A |
0.0135588245836371 |
-0.11377915 |
NSC 372155 |
2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- |
0.0135588245836371 |
0.2017012 |